Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization
Conditions:   Congenital Hemangioma;   Hemangioendothelioma;   Angiosarcoma;   Arteriovenous MalformationIntervention:   Procedure: selective transarterial catheterization using Lipiodol® Ultra Fluid in association with surgical gluesSponsor:   GuerbetNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2015 Category: Research Source Type: clinical trials

Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization
Conditions:   Congenital Hemangioma;   Hemangioendothelioma;   Angiosarcoma;   Arteriovenous MalformationIntervention:   Procedure: selective transarterial catheterization using Lipiodol® Ultra Fluid with surgical gluesSponsor:   GuerbetNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2015 Category: Research Source Type: clinical trials

Lymphatic Anomalies Registry
Conditions:   Lymphatic Malformation;   Generalized Lymphatic Anomaly (GLA);   Central Conducting Lymphatic Anomaly;   CLOVES Syndrome;   Gorham-Stout Disease ("Disappearing Bone Disease");   Blue Rubber Bleb Nevus Syndrome;   Kaposiform Lymphangiomatosis;   Kaposiform Hemangioendothelioma/Tufted Angioma;   Klippel-Trenaunay Syndrome;   LymphangiomatosisIntervention:   Sponsors:   Children's Hospital Boston;   Lymphatic Malformation InstituteRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2015 Category: Research Source Type: clinical trials

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Conditions:   Kaposiform Hemangioendothelioma (KHE);   Kasabach-Merritt Syndrome;   Tufted AngiomaInterventions:   Drug: Vincristine;   Drug: SirolimusSponsors:   Children's Hospital Medical Center, Cincinnati;   PfizerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2014 Category: Research Source Type: clinical trials

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Conditions:   Kaposiform Hemangioendothelioma (KHE);   Kasabach-Merritt Syndrome;   Tufted AngiomaInterventions:   Drug: Vincristine;   Drug: SirolimusSponsors:   Children's Hospital Medical Center, Cincinnati;   PfizerNot yet recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2014 Category: Research Source Type: clinical trials

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Conditions:   Kaposiform Hemangioendothelioma (KHE);   Kasabach-Merritt Syndrome;   Tufted AngiomaInterventions:   Drug: Vincristine;   Drug: SirolimusSponsors:   Children's Hospital Medical Center, Cincinnati;   PfizerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2014 Category: Research Source Type: clinical trials